Status:
COMPLETED
Ewing Sarcoma Family of Tumors (ESFT): A 15-year Experience From a Tertiary Care Cancer Center in Upper Egypt
Lead Sponsor:
Assiut University
Conditions:
Soft Tissue Neoplasms
Bone Neoplasms
Eligibility:
All Genders
Up to 19 years
Brief Summary
The aim of this study is to identify demographic \& disease characteristics in pediatric oncology patients diagnosed with Ewing Sarcoma Family of Tumors (ESFT) \& treatment outcomes in these patients.
Detailed Description
Ewing sarcoma (ES) and peripheral primitive neuroectodermal tumor (PNET), Both entities that currently comprise the same spectrum of neoplastic diseases known as the Ewing sarcoma family of tumors (EF...
Eligibility Criteria
Inclusion
- Patients whose age less than 19 years. Patients diagnosed with Ewing Sarcoma Family of Tumors (ESFT).
Exclusion
- Patients whose age more than 19 years. Patients diagnosed with other bone \& soft tissue neoplasms.
Key Trial Info
Start Date :
July 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 16 2020
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT04300179
Start Date
July 7 2020
End Date
December 16 2020
Last Update
December 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South Egypt Cancer Institute
Asyut, Egypt